Study Finds Vulnerable Point in Crohn’s-linked bacteria According to researchers at Weill Cornell Medicine and New York-Presbyterian, a vulnerable point in a type of gut…
How to Best Manage Crohn’s Disease Dr. Kelly Cushing and Dr. Peter Higgins, two gastorenteroligists at Michigan Medicine, recently published an article in The Journal…
Bristol Myers Squibb seeks to speed the FDA’s review of Zeposia Inherited in Bristol Myers Squibb’s buyout of Celgene, Zeposia is already on the market…
US FDA Approves Priority Review of Opdivo On January 22nd, 2021, the United States Food and Drug Administration (FDA) approved a priority review of Opdivo…
Potential Treatment Of iBD Indicated Result of research, conducted by University of Alabama – Birmingham researcher and professor of medicine, Dr. Charles O. Elson M.D.,…
Skrizi May Lead to Clinical Improvements In a recent study completed by AbbVie, data from two Phase 3 induction studies demonstrates Skyrizi (risankizumab) can lead…